Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 190

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1
Chunk 190
---
 of our outstanding capital stock. Such Class B holders shall continue to have voting control until they hold
under 50.1% of the voting power of our outstanding capital stock, or approximately 583,000 shares of Class B common stock. In addition,
because of the 16.5-to-1 voting ratio between our Class B common stock and Class A common stock, the holders of our Class B common stock
could continue to control a majority of the combined voting power of our common stock and therefore control all matters submitted to
our stockholders for approval until converted by our Class B common stockholders. This concentrated control may limit or preclude your
ability to influence corporate matters for the foreseeable future, including the election of directors, amendments of our organizational
documents and any merger, consolidation, sale of all or substantially all of our assets or other major corporate transactions requiring
stockholder approval. In addition, this concentrated control may prevent or discourage unsolicited acquisition proposals or offers for
our capital stock that you may feel are in your best interest as one of our stockholders. As a result, such concentrated control may
adversely affect the market price of our Class A common stock.

Future
transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock, subject to limited
exceptions as specified in our Certificate of Incorporation, such as transfers to family members and certain transfers effected for estate
planning purposes.

-22-

We
cannot predict the effect our dual-class structure may have on the market price of our Class A common stock.

We
cannot predict whether our dual-class structure will result in a lower or more volatile market price of our Class A common stock, adverse
publicity or other adverse consequences. For example, certain index providers have announced and implemented restrictions on including
companies with multiple-class share structures in certain of their indices. In July 2017, FTSE Russell announced that it would require
new constituents of its indices to have greater than 5% of the company’s voting rights (aggregated across all of its equity securities,
including those that are not listed or trading) in the hands of public stockholders. Pursuant to the FTSE Russell, this 5% minimum voting
rights requirement only applies to companies assigned a Developed market nationality within the FTSE Equity Country Classification scheme,
and, based upon the FTSE Equity Country Classification Interim Announcement published on March 30, 2023, the United States is assigned
a Developed market nationality within